Mid-term outcomes of patients with Lotus and Evolut transcatheter valves.

Postepy Kardiol Interwencyjnej · 2022 · PMC9421513 · PMID 36051828

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

The logrank test showed higher mortality in the Lotus group for all-cause deaths, but this difference did not reach statistical significance ( p = 0.06; RR = 1.8, 95% CI: 0.97–3.3; Figure 1 A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.